These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 10528036

  • 1. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
    Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH.
    N Engl J Med; 1999 Oct 21; 341(17):1264-9. PubMed ID: 10528036
    [Abstract] [Full Text] [Related]

  • 2. Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.
    Tzortzaki EG, Antoniou KM, Zervou MI, Lambiri I, Koutsopoulos A, Tzanakis N, Plataki M, Maltezakis G, Bouros D, Siafakas NM.
    Respir Med; 2007 Aug 21; 101(8):1821-9. PubMed ID: 17391951
    [Abstract] [Full Text] [Related]

  • 3. Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis.
    King TE.
    N Engl J Med; 2000 Mar 30; 342(13):974-5. PubMed ID: 10744491
    [No Abstract] [Full Text] [Related]

  • 4. Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?
    Prasse A, Müller KM, Kurz C, Hamm H, Virchow JC.
    Eur Respir J; 2003 Dec 30; 22(6):906-11. PubMed ID: 14680077
    [Abstract] [Full Text] [Related]

  • 5. Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years.
    Ghanei M, Panahi Y, Mojtahedzadeh M, Khalili AR, Aslani J.
    Pulm Pharmacol Ther; 2006 Dec 30; 19(2):148-53. PubMed ID: 16137903
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosis.
    Ziesche R, Block LH.
    Wien Klin Wochenschr; 2000 Sep 29; 112(18):785-90. PubMed ID: 11072666
    [Abstract] [Full Text] [Related]

  • 7. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
    King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM, INSPIRE Study Group.
    Lancet; 2009 Jul 18; 374(9685):222-8. PubMed ID: 19570573
    [Abstract] [Full Text] [Related]

  • 8. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis.
    Kalra S, Utz JP, Ryu JH, Mayo Clinic Interstitial Lung Diseases Group.
    Mayo Clin Proc; 2003 Sep 18; 78(9):1082-7. PubMed ID: 12962162
    [Abstract] [Full Text] [Related]

  • 9. Interferon-gamma-1b: therapeutic option in advanced idiopathic pulmonary fibrosis?
    Kroegel C, Mock B, Hengst U, Reissig A.
    Respiration; 2004 Sep 18; 71(6):656-7. PubMed ID: 15627882
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.
    Britton J.
    Thorax; 2000 Aug 18; 55 Suppl 1(Suppl 1):S37-40. PubMed ID: 10943637
    [No Abstract] [Full Text] [Related]

  • 12. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
    Antoniou KM, Nicholson AG, Dimadi M, Malagari K, Latsi P, Rapti A, Tzanakis N, Trigidou R, Polychronopoulos V, Bouros D.
    Eur Respir J; 2006 Sep 18; 28(3):496-504. PubMed ID: 16611657
    [Abstract] [Full Text] [Related]

  • 13. Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
    Antoniou KM, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Perisinakis K, Tzortzaki EG, Siafakas NM, Bouros DE.
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun 18; 21(2):105-10. PubMed ID: 15281431
    [Abstract] [Full Text] [Related]

  • 14. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.
    Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE, Idiopathic Pulmonary Fibrosis Study Group.
    N Engl J Med; 2004 Jan 08; 350(2):125-33. PubMed ID: 14711911
    [Abstract] [Full Text] [Related]

  • 15. Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis.
    Kolb M, Kirschner J, Riedel W, Wirtz H, Schmidt M.
    Eur Respir J; 1998 Dec 08; 12(6):1409-14. PubMed ID: 9877500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-gamma 1b: impact of new indications (idiopathic pulmonary fibrosis).
    Aggarwal AN, Behera D.
    Expert Opin Pharmacother; 2000 Dec 08; 1(7):1423-7. PubMed ID: 11249475
    [Abstract] [Full Text] [Related]

  • 18. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.
    Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O.
    Chest; 1999 Aug 08; 116(2):424-31. PubMed ID: 10453872
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 08; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 20. Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis.
    Luppi F, Losi M, D'Amico R, Fabbri LM, Richeldi L.
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul 08; 26(1):64-8. PubMed ID: 19960790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.